MedTrace Logo

Factors Associated With Post-induction Hypotension in iNPH Patient Undergoing VP and LP Shunt

NCT05183061 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 426

Last updated 2022-01-10

No results posted yet for this study

Summary

This study is a retrospective work involving the review of patients who were scheduled for VP or LP shunt in Siriraj Hospital, Mahidol University, Thailand. The sample size calculation was based on the rule of thumbs of the logistic regression comprising 18 risk factors. The incidence of post-induction hypotension according to our institution's pilot study November 2019-January 2020) was 47%. With 10% addition for missing data and other possible reasons, the sample size was 426. The primary objective of the study is to report the factors associated with post-induction hypotension in iNPH patients undergoing VP or LP shunt procedures. Our secondary objective is to determine the incidence of post-induction hypotension in these patients.

Conditions

  • The iNPH Patients Scheduled for VP or LP Shunt Procedures

Interventions

DRUG

Ehedrine Norepineprine

No interventions required considering that this was a retrospective study.

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-01
Primary Completion
2021-11-30
Completion
2021-12-20

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05183061 on ClinicalTrials.gov